ArticleOncotarget2016

Metastatic pathway-specific transcriptome analysis identifies MFSD4 as a putative tumor suppressor and biomarker for hepatic metastasis in patients with gastric cancer.

Mitsuro Kanda et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.